MakeMyTrip Limited - Ordinary Shares (NQ:MMYT)

MakeMyTrip beat Wall Street's Q1 earnings target, but that's not the only reason the stock is rising today.

Why MakeMyTrip Stock Is Skyrocketing Today ↗

August 03, 2026

MakeMyTrip Limited to Report Fiscal 2027 First Quarter Financial & Operating Results on August 03, 2026

Performance

52-Week Range 53.8% below 52-week high

44.62

32.6752W Low 96.6052W High

1 Week 7.8% below 1-week high

45.521W Low 48.421W High

MakeMyTrip Limited - Ordinary Shares (MMYT) traded between $32.67 and $96.60 over the past 52 weeks and last traded at $44.62, 53.8% below its 52-week high. Over the past week it ranged between $45.52 and $48.42.

Past 12 Months

-4.6%

-20.5%

-23.4%

+12.0%

-45.5%

-51.7%

1W -$2.13

1M -$11.51

3M -$13.65

6M +$4.78

YTD -$37.27

1Y -$47.72

MMYT was -51.7% over the past year, +12.0% over six months, -45.5% year to date, -4.6% in the last week.

12 Months vs Market

MMYT

-51.7%

DIA

+10.1%

SPY

+15.1%

QQQ

+24.3%

IWM

+16.1%

Over the past 12 months MMYT returned -51.7% versus DIA (Dow) +10.1%, SPY (S&P 500) +15.1%, QQQ (Nasdaq 100) +24.3% and IWM (Russell 2000) +16.1%.

Volume & Liquidity 2.07× 3-mo avg

Today 1,568,824 3-mo avg 759.6K

964.5K

858.1K

759.6K

988.5K

YTD

1.3M

1.2M

MMYT most recently traded 1,568,824 shares against a 3-month average daily volume of 759.6K.

More News

MakeMyTrip Q1 Earnings Call Highlights ↗

August 03, 2026

Via MarketBeat

Earnings Scheduled For October 28, 2025 ↗

October 28, 2025

Via Benzinga

July 22, 2026

MakeMyTrip (MMYT) Q4 2026 Earnings Transcript ↗

May 19, 2026

MakeMyTrip Limited to Report Fiscal 2026 Fourth Quarter and Full Year Financial & Operating Results on May 19, 2026

MakeMyTrip Q4 Earnings Call Highlights ↗

May 19, 2026

Via MarketBeat

May 06, 2026

MakeMyTrip Deepens AI-First Strategy with OpenAI Collaboration

February 18, 2026

$112 Million Vote of Confidence: This 12.8% Portfolio Bet Signals Conviction in MercadoLibre ↗

January 31, 2026

Palisades Investment Initiated a Position in Travere Therapeutics Worth Over $5 Million. Is the Stock a Buy? ↗

January 25, 2026

Palisades Investment Initiated a Position in Travere Therapeutics Worth Over $5 Million. Is the Stock a Buy? ↗

January 24, 2026

Why Did MakeMyTrip Stock Fall Today? ↗

January 21, 2026

Via Stocktwits

MakeMyTrip (MMYT) Q3 2026 Earnings Call Transcript ↗

January 21, 2026

MakeMyTrip Limited to Report Fiscal 2026 Third Quarter Financial & Operating Results on January 21, 2026

January 12, 2026

MakeMyTrip Limited Announces Repurchase Right Notification for 0.00% Convertible Senior Notes due 2028

January 13, 2026

India's Silver Rush: Festival Frenzy and Global Flows Ignite Unprecedented Surge, With Unexpected Ripple Effects on Travel

November 21, 2025

Via MarketMinute

10 Consumer Discretionary Stocks With Whale Alerts In Today's Session ↗

November 12, 2025

Via Benzinga

10 Consumer Discretionary Stocks With Whale Alerts In Today's Session ↗

November 10, 2025

Via Benzinga

Prosus Fuels India’s Travel Tech Ascent with $146M Ixigo Investment, Eyeing AI-Driven Future

November 03, 2025

Via TokenRing AI

This Small-Cap Fund Just Bet $7 Million on Root’s Comeback ↗

November 01, 2025

This Small-Cap Fund Just Dumped $7 Million in ADMA Stock — Here’s Why ↗

November 01, 2025

12 Consumer Discretionary Stocks Moving In Tuesday's Intraday Session ↗

October 28, 2025

Via Benzinga

MakeMyTrip (MMYT) Q2 2026 Earnings Call Transcript ↗

October 28, 2025

MakeMyTrip Limited to Report Fiscal 2026 Second Quarter Financial & Operating Results on October 28, 2025

October 16, 2025